Yan Zhang, Ph.D.

Assistant Professor, Biological Chemistry

Ofc: 3220A MSRB III

Lab: 3240 MSRB III

1150 W. Medical Center Drive

Ann Arbor, MI 48109-5606

 

(734) 647-5830

Areas of Interest

CRISPR-Cas is a RNA-guided, genetic interference pathway in prokaryotes that enables acquired immunity against invasive nucleic acids. Nowadays, CRISPRs also provide formidable tools for facile, programmable genome engineering in eukaryotes. Cas9 proteins are the “effector” endonucleases for CRISPR interference; and have recently begun to be also recognized as important players in other aspects of bacterial physiology (e.g. acquisition of new spacers into CRISPRs, endogenous gene regulation, and microbial pathogenesis, etc.). My laboratory is broadly interested in CRISPR biology and mechanism. We will use Neisseria species as our model system, and E. coli and human cells as additional platforms. We employ complementary biochemical, microbiological, genetic and genomic approaches. We are also interested in working with the broader scientific community to develop and apply novel CRISPR-based tools to tackle diverse biological questions.  

Published Articles or Reviews

Recent Publications

Biochemical characterization of RNA-guided ribonuclease activities for CRISPR-Cas9 systems.
Gramelspacher MJ, Hou Z, Zhang Y.
Methods. 2019; in press.

Inserting DNA with CRISPR.
Hou Z, Zhang Y.
Science. 2019; 365: 25-6.

Introducing a Spectrum of Long-Range Genomic Deletions in Human Embryonic Stem Cells Using Type I CRISPR-Cas.
Dolan AE, Hou Z, Xiao Y, Gramelspacher MJ, Heo J, Howden SE, Freddolino PL, Ke A, Zhang Y.
Mol Cell. 2019; 74: 936-50.

Insights into a Mysterious CRISPR Adaptation Factor, Cas4.
Hou Z, Zhang Y.
Mol Cell. 2018; 70: 757-8.

Programmable RNA Cleavage and Recognition by a Natural CRISPR-Cas9 System from Neisseria meningitidis.
Rousseau BA, Hou Z, Gramelspacher MJ, Zhang Y.
Mol Cell. 2018; 69: 906-14.

The CRISPR-Cas9 system in Neisseria spp.
Zhang Y.
Pathog Dis. 2017; 75: ftx036.

Naturally Occurring Off-Switches for CRISPR-Cas9.
Pawluk A, Amrani N, Zhang Y, Garcia B, Hidalgo-Reyes Y, Lee J, Edraki A, Shah M, Sontheimer EJ, Maxwell KL, Davidson AR.
Cell. 2016; 167: 1829-38.

DNase H Activity of Neisseria meningitidis Cas9.
Zhang Y, Rajan R, Seifert HS, Mondragón A, Sontheimer EJ.
Mol Cell. 2015; 60: 242-55.

For a list of publications from Pubmed, click HERE

Web Sites